Literature DB >> 775683

Production of specific antisera to human B lymphocytes.

P Goodfellow, C Barnstable, E Jones, W F Bodmer, M J Crumpton, D Snary.   

Abstract

Antisera have been prepared, in mice and rabbits, to membrane and sub-membrane fractions of human B lymphocyte derived lymphoid lines. Antisera to a protein subfraction were, after only minimal absorption, specific for human peripheral B lymphocytes, monocytes and B cell derived lymphoid lines. The antigen(s) recognised by these antisera were not the same as the previously described B-cell markers; immunoglobulin, Fc receptor, complement receptor and Ia antigens. The antigen(s) could not be removed from cells by lysostrip with anti- beta2 microglobulin.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 775683     DOI： 10.1111/j.1399-0039.1976.tb01039.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN： 0001-2815


  5 in total

1.  Chromosomal assignments of the genes coding for human types II, III, and IV collagen: a dispersed gene family.

Authors:  E Solomon; L R Hiorns; N Spurr; M Kurkinen; D Barlow; B L Hogan; R Dalgleish
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  A monoclonal antibody to the HLA-DR product recognizes a polymorphic Ia determinant in mice.

Authors:  P M Brickell; I McConnell; C Milstein; B Wright
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

3.  Biosynthesis of the first component of complement by human fibroblasts.

Authors:  K B Reid; E Solomon
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

4.  Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes.

Authors:  D A Brooks; I Beckman; J Bradley; P J McNamara; M E Thomas; H Zola
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

5.  Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.

Authors:  L V Crawford; D C Pim; E G Gurney; P Goodfellow; J Taylor-Papadimitriou
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.